Phase 1 trial of the anti-LAG3 antibody favezelimab plus pembrolizumab in advanced gastric cancer.

Rha, SY; Miller, WH; de Miguel, MJ; Im, SA; Lugowska, I; Wermke, M; Kotani, D; Bauer, TM; Takashima, A; Palcza, J; Chaney, MF; Dobrenkov, K; Garralda, E

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (): 394

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索